Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Early clinical results presented for ABX-IL-8 in psoriasis

Feb. 17, 1999

Fresenius will distribute Genzyme's Sepra products in select European markets

Feb. 17, 1999

Health Canada approves first active wound-healing agent

Feb. 16, 1999

AxyS initiates phase Ib studies of APC-2059 in psoriasis

Feb. 16, 1999

Human Genome Sciences initiates phase II clinical trials of new wound-healing agent

Feb. 15, 1999

Pierre Fabre Dermatologie to commercialize Allergan's Zorac in Europe

Feb. 12, 1999

ADCON-L improves clinical outcome following lumbar discectomy

Feb. 11, 1999

Micrologix Biotech continues preclinical testing on acne drugs

Feb. 8, 1999

Schering discloses new leukotriene antagonists particularly useful as dermatological products

Feb. 3, 1999

Gliatech initiates ADCON-P pivotal clinical trial

Jan. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...